Combined evaluation of CD8IE and FoxP3IS could help to refine risk stratification in colorectal cancer. Investigation of FoxP3IS cells as an immunotherapy target in colorectal cancer might be merited.
Combined evaluation of CD8IE and FoxP3IS could help to refine risk stratification in colorectal cancer. Investigation of FoxP3IS cells as an immunotherapy target in colorectal cancer might be merited.
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Privacy Policy